Livagen Research Guide

Full name: Livagen (Lys-Glu-Asp-Ala Liver/Lymphocyte Bioregulator)

A short synthetic peptide bioregulator from the Khavinson family (an analog related to Vilon) associated with liver tissue and lymphocyte function. Used in the bioregulator community for liver support and chromatin/gene-expression effects.

How Livagen Works

As a signal peptide (Lys-Glu-Asp-Ala), it is proposed to decondense chromatin (heterochromatin) in lymphocytes and regulate gene expression in hepatic tissue, supporting liver function and cellular activity.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Liver function support
• Lymphocyte chromatin activation (proposed)
• Detox/antioxidant support
• Short course-based protocol

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Livagen chromatin decondensation (2003) - Reported to decondense heterochromatin and activate gene expression in human lymphocytes in cell studies.

Related Detox & Antioxidant Compounds

• Glutathione (IV/IM) - Full Profile
• NAC - Full Profile
• EDTA Chelation - Full Profile
• Activated Charcoal - Full Profile
• PQQ - Full Profile
• TUDCA - Full Profile

View full Livagen profile with 3D molecule viewer →